Listen Now

Topics Covered

  • Definition of Diagnostic Technologies for People Living with Solid Cancer Tumors, in the Context of COVID-19
  • How Diagnostic Technologies Work & Are Used
  • Examples of How Diagnostic Technologies Inform/Transform the Treatment of Solid Cancer Tumors
  • Predicting Hereditary Risk
  • Diagnostic Technologies, Targeted Therapies & Precision Medicine
  • Clinical Trial Updates, in the Context of COVID-19
  • Their Benefits
  • Current Application for People Living with Solid Cancer Tumors
  • The Increasing Role of Telehealth/Telemedicine Appointments, in the Context of COVID-19
  • Questions for Our Panel of Experts

Our Panel of Experts

Mark G. Kris, MD

William and Joy Ruane Chair in Thoracic Oncology, Attending Physician, Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Professor of Medicine, Weill Cornell Medical College

Al B. Benson, III, MD, FACP, FASCO

Professor of Medicine, Associate Director for Cooperative Groups, Robert H. Lurie Comprehensive Cancer Center, Northwestern University

Kamel Abou Hussein, MD

Lead Physician, Breast Medical Oncology, MD Anderson at Cooper Cancer Center

Sarah E. Kerr, MD

Pathologist, Hospital Pathology Associates, P.A., Divisions of Cytopathology; Gynecologic and Perinatal Pathology; Molecular Diagnostic Lead Pathologist for Next Generation Sequencing Development and Practice, Allina Health Laboratory (A Part of Abbott Northwestern Hospital)

Sarah Thibault-Sennett, PhD

Senior Manager, Public Policy & Advocacy, Association for Molecular Pathology (AMP)

Carolyn Messner, DSW, OSW-C, FAPOS, FAOSW

Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop(pdf)(96.3 KB)

Workshop Date

This workshop was originally recorded on May 17, 2021.

Browse by Diagnosis

Browse by Topic

The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top
Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.